Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

doi:10.1016/j.biopha.2018.01.123

Paper

Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

Published Mar 1, 2018 · Yundong Xie, Zizhang Chen, Na Li

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Q1 SJR score

17

Citations

1

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Rigorous Journal

Study Snapshot

Hydroxytyrosol nicotinate (HT-N) has hypolipidemic, hypoglycemic, and antioxidant properties, potentially serving as a multifunctional therapeutic strategy for diabetic patients with hyperlipidemia.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent.

References

Citations